|
|
|
|
| Advertisement |
Watch this brief video to learn how analytics can help your product access program.
 Learn more |
|
| Advertisement |
NORD's Rare Diseases and Orphan Products Breakthrough Summit
is the most meaningful multi-stakeholder event – historically featuring over 20 speakers from the FDA, participation from over 80 patient organizations and the Pharma/Biotech industry's foremost experts in orphan product innovation, investment and commercialization.
The 2016 Summit is your opportunity to address the progress and innovations in rare disease diagnosis, treatment, engagement and access of orphan products.
 Learn more |
|
| Advertisement |
Breaking the Circle of Distrust with a Radical PLC Pricing Model
On Demand
 Learn more |
|
| Special Feature |
 |
|
Pharm Exec's Top 50 Companies |
Pharm Exec's 16th annual listing of the top biopharma players may look placid on the surface, but, upon deeper inspection, does point to important transitions taking place in the larger business model.
... /Read more/ |
|
|
|
| Calendar |
|
|
| Advertisement |
Best Practices for Integrating Biomarkers
across the Drug Development Continuum
On Demand
 Learn more |
|
|
   |
| Industry update |
| //German-American diagnostics company Epigenomics AG (Berlin, Germany and Germantown, MD) appointed Gregory Hamilton as Chief Executive Officer.//Aarti Shah has been promoted to Senior VP and Chief Information Officer at Lilly, moving up from a role as the firm's global brand development leader for immunology.// |
|
| Advertisement |
Considering Biosimilars: A Panel Discussion Exploring Perceptions and Potential Adoption
On Demand
 Learn more |
|
|
|
| |
|
